Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults

Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults

Artemisinin-based combination therapies (ACTs) have contributed substantially to the global decline in Plasmodium falciparum morbidity and mortality, but resistance to artemisinins and their partner drugs is increasing in Southeast Asia, threatening malaria control. New antimalarial compounds will n...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hanboonkunupakarn, B, Van Der Pluijm, R, Hoglund, R, Pukrittayakamee, S, Winterberg, M, Mukaka, M, Waithira, N, Chotivanich, K, Singhasivanon, P, White, N, Dondorp, A, Tarning, J, Jittamala, P
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	American Society for Microbiology 2019

Míreanna comhchosúla

Safety, pharmacokinetics, and mosquito‐lethal effects of ivermectin in combination with dihydroartemisinin‐piperaquine and primaquine in healthy adult Thai subjects
de réir: Kobylinski, KC, et al.
Foilsithe / Cruthaithe: (2019)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
de réir: Chotsiri, P, et al.
Foilsithe / Cruthaithe: (2017)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
de réir: Hanboonkunupakarn, B, et al.
Foilsithe / Cruthaithe: (2014)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
de réir: Von Seidlein, L, et al.
Foilsithe / Cruthaithe: (2019)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
de réir: Tarning, J, et al.
Foilsithe / Cruthaithe: (2024)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
de réir: Lorenz von Seidlein, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
de réir: Joel Tarning, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
de réir: Rijken, M, et al.
Foilsithe / Cruthaithe: (2011)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
de réir: Valecha, N, et al.
Foilsithe / Cruthaithe: (2010)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
de réir: Valecha, N, et al.
Foilsithe / Cruthaithe: (2010)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
de réir: Neena Valecha, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
de réir: Tarning, J, et al.
Foilsithe / Cruthaithe: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
de réir: Tarning, J, et al.
Foilsithe / Cruthaithe: (2012)

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
de réir: van Der Pluijm, R, et al.
Foilsithe / Cruthaithe: (2019)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
de réir: Neena Valecha, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
de réir: Neena Valecha, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
de réir: Awab, G, et al.
Foilsithe / Cruthaithe: (2010)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
de réir: Tarning, J, et al.
Foilsithe / Cruthaithe: (2008)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
de réir: Tarning, J, et al.
Foilsithe / Cruthaithe: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
de réir: Smithuis, F, et al.
Foilsithe / Cruthaithe: (2006)

Pharmacokinetics of piperaquine and safety profile of dihydroartemisinin-piperaquine co-administered with antiretroviral therapy in malaria-uninfected HIV-positive Malawian adults
de réir: Banda, C, et al.
Foilsithe / Cruthaithe: (2018)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
Foilsithe / Cruthaithe: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
Foilsithe / Cruthaithe: (2010-01-01)

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated <it>Plasmodium falciparum</it> malaria in India
de réir: Gargano Nicola, et al.
Foilsithe / Cruthaithe: (2012-07-01)

Efficacy and safety of dihydroartemisinin-piperaquine.
de réir: Myint, H, et al.
Foilsithe / Cruthaithe: (2007)

A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
de réir: Saito, M, et al.
Foilsithe / Cruthaithe: (2021)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
de réir: Zongo, I, et al.
Foilsithe / Cruthaithe: (2014)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
de réir: Permala, J, et al.
Foilsithe / Cruthaithe: (2017)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
de réir: Woodrow Charles J, et al.
Foilsithe / Cruthaithe: (2010-04-01)

A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border
de réir: Makoto Saito, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
de réir: Phuc, B, et al.
Foilsithe / Cruthaithe: (2017)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
de réir: Mytton, O, et al.
Foilsithe / Cruthaithe: (2007)

Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand
de réir: Khine Nwe Win, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
de réir: Jittamala, P, et al.
Foilsithe / Cruthaithe: (2015)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
de réir: Chotsiri, P, et al.
Foilsithe / Cruthaithe: (2019)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
de réir: Byakika-Kibwika, P, et al.
Foilsithe / Cruthaithe: (2019)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
de réir: Lwin, K, et al.
Foilsithe / Cruthaithe: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
de réir: Lwin, K, et al.
Foilsithe / Cruthaithe: (2012)

An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
de réir: Mayxay, M, et al.
Foilsithe / Cruthaithe: (2006)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
de réir: Jittamala, P, et al.
Foilsithe / Cruthaithe: (2014)